Reusable Pen is a reusable, mechanical injection device for standard 3 ml cartridges, enabling precise, incremental dosing of peptides, HGH and other active substances. The device features an integrated needle guard, is designed for multiple uses and meets the hygiene requirements of the medical profession.
Reusable Pen is a mechanical injection device specifically designed for use with standardized 3 ml cartridges, enabling controlled, reproducible administration of peptides, HGH preparations, and GLP-1 analogues. The device operates on the principle of a stepwise ratchet mechanism: the user turns the dosing knob to the desired value, attaches a compatible
| Parameter | Specification | Note |
|---|---|---|
| Cartridge volume | 3 ml (standard) | Other volumes not compatible |
| Dosing range | 0.01–1.00 ml per injection | Depending on cartridge content and concentration |
| Increment | 0.01 ml or 0.1 ml (depending on setting) | Ratchet mechanism, stepless adjustment not possible |
| Needle compatibility | 29G–32G, 4–8 mm | Order pen needles separately |
| Maximum daily doses | As per medical prescription | Device does not impose a dose limit |
| Cartridge change | < 60 seconds | No tools required, screw system |
| Cleaning | Outer surfaces with alcohol swab | Do not autoclave the complete device |
Reusable Pen is a mechanical injection device designed specifically for use with standardised 3 ml cartridges, enabling controlled, reproducible administration of peptides, HGH preparations and GLP-1 analogues. The device operates on a stepped ratchet mechanism: the user turns the dose dial to the desired value, attaches a compatible pen needle and performs the injection subcutaneously. The set dose is delivered precisely by the mechanical plunger drive, minimising the risk of over- or under-dosing.
The pen accepts standard 3 ml glass cartridges, as used with Norditropin, Genotropin and comparable growth hormone preparations, as well as lyophilised peptide formulations (e.g. BPC-157, TB-500 after reconstitution). The cartridge is inserted into the pen body and secured by a screw-fixing system; a cartridge change takes under 60 seconds in practice. The dose dial allows settings in defined increments (typically 0.01–0.1 ml per step, depending on cartridge format), enabling individually tailored dosing without additional measuring equipment.
The Reusable Pen features an integrated needle guard (needle cap retention system) that prevents accidental triggering of the injection and protects the user from needle-stick injuries. The housing is made from medical-grade polycarbonate, which is chemically resistant to common reconstitution solutions (water for injections, bacteriostatic water, 0.9% NaCl). All product-contact internal components are made from pharmaceutically approved materials; the pen is sterilisable and designed for repeated use. The mechanical precision of the ratchet mechanism meets the dosing accuracy requirements of ISO 11608-1 (needle requirements for injection systems) and ensures a deviation of less than ±2% from the set dose value.
Reusable Pen is suitable for all subcutaneous applications using standard 3 ml cartridges. Compatible product groups include recombinant growth hormones (HGH) in cartridge form, reconstituted peptides (BPC-157, TB-500, CJC-1295, Ipamorelin) and semaglutide and tirzepatide formulations in cartridge format. The device is not designed for disposable pre-filled pens and is not compatible with ampoules or vials. The use of pen needles sized 29G–32G × 4–8 mm is recommended; these are available separately. The pen is supplied as a single unit (1 pen), without cartridge and without needles.
Pharmacona is a manufacturer specialising in pharmaceutical application systems, developing and producing injection devices for use with standardised cartridge formats. The Reusable Pen is manufactured under controlled production conditions and complies with the requirements of the ISO 11608 series of standards for needle injection systems. Pharmacona focuses on specialist trade distribution and the supply of users who require precise application aids for peptides, HGH and GLP-1 analogues. Quality control and material selection follow pharmaceutical industry standards.
| Brand | Pharmacona |
|---|---|
| Also known as | Injektionspen, Insulin-Pen, wiederverwendbarer Pen, Karpulen-Pen, Reusable Pen, Pharmacona Pen |
| Form | Gerät |
| Item number | OTHER-XXX-PHA-001 |
No reviews yet. Be the first to review this product.
Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.
Community FavoriteDMAA Rapid is an oral stimulant from Knoll Pharmaceuticals delivering 50 mg of 1,3-Dimethylamylamine (DMAA) per tablet. The product is aimed at athletes in a bodybuilding context who want targeted support for focus, energy availability and thermogenic effect before training.
Pro ChoiceTAD 600 is an injectable glutathione preparation containing 600 mg reduced L-glutathione per 4 ml vial, manufactured by Biomedica Foscama. It supports hepatoprotective processes, promotes cellular detoxification and acts as a potent endogenous antioxidant – particularly relevant under elevated liver stress caused by anabolic substances. ---
Pairs well with these products.
High ConcentrationQuant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.
Long-Acting FormulaBolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.
Brand QualityEquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.
Pro ChoiceDragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.